Trials / Completed
CompletedNCT02558088
Pharmacological Properties of Salmeterol
Pharmacological Properties of Inhaled Salmeterol in Healthy Trained Males
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- University of Copenhagen · Academic / Other
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The objective of the study is to help establish a urinary threshold for salmeterol on the World Anti-doping Agency prohibited list, to avoid supratherapeutic of this substance in competitive sports. Hence, there is no hypothesis as such.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Salmeterol |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2016-07-01
- Completion
- 2016-07-01
- First posted
- 2015-09-23
- Last updated
- 2017-01-31
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02558088. Inclusion in this directory is not an endorsement.